Published in Gene Therapy Weekly, June 5th, 2003
The trial included ten patients with advanced cancer. Half of the patients were treated with once-weekly 2 x 1012 particle doses of ONYX-015 in combination with irinotecan (CPT11) and 5-fluorouracil (5FU) for 6 weeks. The others received a 10-fold lower dose of ONYX-015 for 6 weeks that was combined with 4...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly